According to fresh research from the Radicati Group Inc, the market is being driven off the back of legislative pressure in the US to comply with mandates such as SEC 17a-4, NASD 3010, FDA Rule 21, HIPAA, Sarbanes-Oxley, and the Patriot Act in the US. The Palo Alto, California-based research company expects the segment to top $420m by 2005.

This article is based on material originally published by ComputerWire